Kankan Qu
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Establishment of a Novel Approach for Drug Abuse Monitoring and Its Application in Medical Institutions.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 27, 2026
Gut-derived IL-17A via STAT3/RORγt signaling underlies sleep disruption-induced depression: Targeting effects of Schisandrin B therapy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 28, 2025
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment.
Journal: Pharmacopsychiatry
Published: August 26, 2024
Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database.
Journal: Journal of psychopharmacology (Oxford, England)
Published: April 20, 2024
Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database.
Journal: Asian journal of psychiatry
Published: September 16, 2023
Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data.
Journal: International clinical psychopharmacology
Published: July 02, 2022
The Association Between Clozapine Plasma Concentration, CYP2D6 (*10, *2) Polymorphisms and Risk of Adverse Reactions.
Journal: Psychiatry and clinical psychopharmacology
Published: March 17, 2022
A novel and sensitive method for determination of amisulpride in human plasma by two-dimensional liquid chromatography.
Journal: Biomedical chromatography : BMC
Published: November 02, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026